Juvenile Diabetes

The Lancet details a miracle treatment which is successful in treatment of neonatal diabetes (babies with diabetes) over the long-term, providing excellent sugar control after 10 years.

A team of researchers led has developed a unique approach for halting the progression of Type I (juvenile or insulin-dependent) diabetes.

Despite laboratory evidence that zinc helps promote the production and action of insulin, and widespread marketing of zinc supplements for this purpose, no randomized clinical trials show that zinc supplementation prevents the onset of type 2 diabetes.

A very high proportion of children who are having surgery are overweight or obese, and because of the excess weight have a greater chance of experiencing problems associated with the surgery, according to a new study.

Safe and effective therapy discovered to reduce insulin requirements and hypoglycemic episodes in certain Type 1 diabetics using a common blood pressure drug.

Researchers help create a closed-loop artificial pancreas to automatically monitor blood sugar levels and administer insulin to patients with Type 1 diabetes.

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.

Teens at risk of developing diabetes can prevent or delay its onset through strength training exercise, a University of Southern California study has found.

The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the lymph nodes at the "gates" of the pancreas.

A gene commonly studied by cancer researchers has been linked to the metabolic inflammation that leads to diabetes.

Research has revealed two new genetic causes of neonatal diabetes.

Majority of those surveyed expressed an interest in a peer mentoring program to improve diabetes control.

Researchers have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin.

A high-fat diet during pregnancy may program a woman's baby for future diabetes, even if she herself is not obese or diabetic.

A new method that uses nanotechnology to rapidly measure minute amounts of insulin is a major step toward developing the ability to assess the health of the body's insulin-producing cells in real time.

Children with more fat around their midsections could be at a higher risk of developing cardiovascular disease later in life, researchers say.